Is GRVI or JNJ a better dividend investment in 2026?

GRVI currently yields 40.40% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: GRVI offers higher current income.

What is the dividend yield difference between GRVI and JNJ?

GRVI has a forward dividend yield of 40.40% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 37.04 percentage points.

Home › Compare › GRVI vs JNJ

GRVI vs JNJ: Dividend Comparison 2026

GRVI yields 40.40% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GRVI wins by $217.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

GRVI

● Live price

40.40%

Share price

$4.95

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$237.0K

Annual income

$40,387.73

Full GRVI calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — GRVI vs JNJ

📍 GRVI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GRVI	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GRVI + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GRVI pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GRVI

Annual income on $10K today (after 15% tax)

$3,434.34/yr

After 10yr DRIP, annual income (after tax)

$34,329.57/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, GRVI beats the other by $33,625.96/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GRVI + JNJ for your $10,000?

GRVI: 50%JNJ: 50%

100% JNJ50/50100% GRVI

Portfolio after 10yr

$128.5K

Annual income

$20,607.75/yr

Blended yield

16.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GRVI

No analyst data

Price Target

$6.00

+21.2% upside vs current

Range: $6.00 — $6.00

Altman Z

-1.5

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GRVI buys

JNJ buys

No recent congressional trades found for GRVI or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGRVIJNJ

Forward yield	40.40% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$237.0K ✓	$20.0K
Annual income after 10y	$40,387.73 ✓	$827.78
Total dividends collected	$178.8K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst price target	$6.00	$228.73 ✓

Year-by-year: GRVI vs JNJ ($10,000, DRIP)

Year	GRVI Portfolio	GRVI Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$14,740	$4,040.40	$10,676	$355.77	+$4.1K → GRVI
2	$21,338	$5,566.09	$11,407	$389.39	+$9.9K → GRVI
3	$30,362	$7,530.39	$12,198	$426.53	+$18.2K → GRVI
4	$42,502	$10,014.05	$13,056	$467.62	+$29.4K → GRVI
5	$58,578	$13,100.78	$13,987	$513.12	+$44.6K → GRVI
6	$79,553	$16,874.79	$14,998	$563.56	+$64.6K → GRVI
7	$106,540	$21,417.98	$16,098	$619.52	+$90.4K → GRVI
8	$140,804	$26,807.08	$17,295	$681.69	+$123.5K → GRVI
9	$183,772	$33,110.91	$18,599	$750.82	+$165.2K → GRVI
10	$237,023	$40,387.73	$20,022	$827.78	+$217.0K → GRVI

GRVI vs JNJ: Complete Analysis 2026

GRVI — Stock

Grove, Inc., through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol. The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors. It also operates annual tradeshow related to the CBD industry in the United States. The company was incorporated in 2018 and is headquartered in Henderson, Nevada.

Full GRVI Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this GRVI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GRVI vs SCHD GRVI vs JEPI GRVI vs O GRVI vs KO GRVI vs MAIN GRVI vs ABBV GRVI vs MRK GRVI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.